Stefano Giardino
Overview
Explore the profile of Stefano Giardino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Faraci M, Nobile G, Nobili L, Masetti R, Cordelli D, Toni F, et al.
J Pediatr Hematol Oncol
. 2021 Mar;
44(1):e168-e175.
PMID: 33661175
Objectives: Drug resistant epilepsy has rarely been reported following posterior reversible encephalopathy syndrome (PRES), with few cases of mesial temporal sclerosis (MTS). The aim of this study was to report...
22.
DellOrso G, Faraci M, Giardino S, Mariani M, Mesini A, Castagnola E
J Chemother
. 2021 Jan;
33(7):517-518.
PMID: 33459210
No abstract available.
23.
Faraci M, Giardino S, Podesta M, Pierri F, DellOrso G, Beccaria A, et al.
Rheumatology (Oxford)
. 2021 Jan;
60(10):4850-4854.
PMID: 33410495
Objective: Mevalonic aciduria represents the most severe form of mevalonate kinase deficiency (MKD). Patients with mevalonic aciduria have an incomplete response even to high doses of anti-cytokine drugs such as...
24.
Giardino S, Bava C, Arrigo S, Pierri F, Gandullia P, Coccia C, et al.
Pediatr Transplant
. 2020 Dec;
25(3):e13941.
PMID: 33314581
Background: Autoimmune diseases may occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and inflammatory bowel disease (IBD or Crohn disease) is rarely described. We describe a child who developed CD...
25.
Berger M, Faraci M, Saglio F, Giardino S, Ernestina Vassallo E, Prete A, et al.
Pediatr Transplant
. 2020 Nov;
25(5):e13909.
PMID: 33141997
Background: PGF is historically associated with high morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods: In this study, we report our multicenter experience on stem cell boost...
26.
DellOrso G, Giardino S, Pierri F, Volpi S, Mesini A, Paladini D, et al.
Pediatr Blood Cancer
. 2020 Oct;
68(4):e28783.
PMID: 33112030
No abstract available.
27.
Giardino S, Piccardo A, Conte M, Puntoni M, Bertelli E, Sorrentino S, et al.
Pediatr Blood Cancer
. 2020 Oct;
68(2):e28775.
PMID: 33099289
Introduction: Despite the progress in current treatments, the event-free survival of high-risk neuroblastoma (HR-NB) patients does not exceed 40%-50%, and the prognosis of refractory or relapsed patients is poor, still...
28.
Giardino S, de Latour R, Aljurf M, Eikema D, Bosman P, Bertrand Y, et al.
Am J Hematol
. 2020 Apr;
95(7):809-816.
PMID: 32267023
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is curative for bone marrow failure in patients with Fanconi anemia (FA), but the presence of a malignant transformation is associated with a poor...
29.
Faraci M, Ricci E, Bagnasco F, Pierri F, Giardino S, Girosi D, et al.
Pediatr Pulmonol
. 2020 Jan;
55(3):631-637.
PMID: 31951682
Background: The onset of bronchiolitis obliterans (BO) as a pulmonary manifestation of chronic graft vs host disease dramatically changes the prognosis of children undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT)....
30.
Castagnola E, Mesini A, Saffioti C, Moscatelli A, Pierri F, Giardino S, et al.
Transpl Infect Dis
. 2019 Dec;
22(1):e13231.
PMID: 31846143
Once-a-week cotrimoxazole is an effective prophylaxis for pneumocystosis during antineoplastic chemotherapy or autologous stem cell transplant. Following allogeneic stem cell transplant, this schedule is at risk of pneumocystosis or neurotoxoplasmosis,...